Abstracts de Psiquiatría
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe
The Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 Autores: Dragana Bugarski-Kirola, MD , Prof Celso Arango, MD, Prof...
Association of school absence and exclusion with recorded neurodevelopmental disorders, mental disorders, or self-harm: a nationwide, retrospective, electronic cohort study...
Lancet Psychiatry Fecha de publicación: 1 de enero de 2022 DOI: https://doi.org/10.1016/S2215-0366(21)00367-9 Autores: Prof Ann John, MD , Yasmin Friedmann, PhD,...
Anxiety disorders and age-related changes in physiology
British Journal of Psychiatry Fecha de publicación: 6 de enero de 2022 Autores: Julian Mutz, Thole H. Hoppen, Chiara Fabbri...
Predicting relapse or recurrence of depression: systematic review of prognostic models
British Journal of Psychiatry Fecha de publicación: 11 de enero de 2022 Autores: Andrew S. Moriarty ,Nicholas Meader, Kym I....
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts
American Journal of Psychiatry Fecha de publicación: 14 de mayo de 2021 Autores: Travis T. Mallard, M.A., Jeanne E. Savage, Ph.D., Emma C. Johnson, Ph.D., Yuye...
Lo más popular
Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta... 
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: R... 
Artistic creativity and risk for schizophrenia, bipolar disorder and unipolar depression:... 
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffect... 
Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 rand... 
Polygenic Risk: Predicting Depression Outcomes in Clinical and Epidemiological Cohorts of... 
Anxiety disorders and age-related changes in physiology